Auranofin
NDC 85437-093, auranofin, capsule, from Coral Way Pharma, LLC.
- Product NDC
- 85437-093
- Status
- Listed
- Labeler
- Coral Way Pharma, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA018689
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85437-093 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AURANOFIN3 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85437-093-06 | 85437009306 | 60 CAPSULE in 1 BOTTLE (85437-093-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d688978b-8b91-4377-9f1d-89b805f5747c
Use it
Look up 85437-093 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85437-093 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85437-093. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.